-
2
-
-
0038351753
-
IARC
-
IARC, Lyon
-
IARC, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs, vols. 1-42, Suppl. 7, IARC, Lyon, 1987, pp. 100-106.
-
(1987)
Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs
, vol.1-42
, Issue.7 SUPPL.
, pp. 100-106
-
-
-
3
-
-
0002897083
-
Arsenic
-
in: T.W. Clarkson, L. Friberg, G.F. Nordberg, P.R. Sager (Eds.), Elsevier/Plenum Press, New York
-
M.E. Vahter, Arsenic, in: T.W. Clarkson, L. Friberg, G.F. Nordberg, P.R. Sager (Eds.), Biological Monitoring of Toxic Metals, Elsevier/Plenum Press, New York, 1988, pp. 303-321.
-
(1988)
Biological Monitoring of Toxic Metals
, pp. 303-321
-
-
Vahter, M.E.1
-
4
-
-
0024347404
-
Dimethylated arsenics induced DNA strand breaks in lung via the production of active oxygen in mice
-
Yamanaka K., Hasegawa A., Sawamura R., Okada S. Dimethylated arsenics induced DNA strand breaks in lung via the production of active oxygen in mice. Biochem. Biophys. Res. Commun. 165:1989;43-50.
-
(1989)
Biochem. Biophys. Res. Commun.
, vol.165
, pp. 43-50
-
-
Yamanaka, K.1
Hasegawa, A.2
Sawamura, R.3
Okada, S.4
-
5
-
-
0025274032
-
Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical
-
Yamanaka K., Hoshino M., Okamoto M., Sawamura R., Hasegawa A., Okada S. Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical. Biochem. Biophys. Res. Commun. 168:1990;58-64.
-
(1990)
Biochem. Biophys. Res. Commun.
, vol.168
, pp. 58-64
-
-
Yamanaka, K.1
Hoshino, M.2
Okamoto, M.3
Sawamura, R.4
Hasegawa, A.5
Okada, S.6
-
6
-
-
0029877529
-
Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenesis initiated by 4-nitroquinoline 1-oxide in the lungs of mice
-
Yamanaka K., Ohtsubo K., Hasegawa A., Hayashi H., Ohji H., Kanisawa M., Okada S. Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenesis initiated by 4-nitroquinoline 1-oxide in the lungs of mice. Carcinogenesis. 17:1996;767-770.
-
(1996)
Carcinogenesis
, vol.17
, pp. 767-770
-
-
Yamanaka, K.1
Ohtsubo, K.2
Hasegawa, A.3
Hayashi, H.4
Ohji, H.5
Kanisawa, M.6
Okada, S.7
-
7
-
-
0032513095
-
Dimethylarsinic acid, a main metabolite of inorganic arsenics, has tumorigenicity and progression effects in the pulmonary tumors of A/J mice
-
Hayashi H., Kanisawa M., Yamanaka K., Ito T., Udaka N., Ohji H., Okudera K., Okada S., Kitamura H. Dimethylarsinic acid, a main metabolite of inorganic arsenics, has tumorigenicity and progression effects in the pulmonary tumors of A/J mice. Cancer Lett. 125:1998;83-88.
-
(1998)
Cancer Lett.
, vol.125
, pp. 83-88
-
-
Hayashi, H.1
Kanisawa, M.2
Yamanaka, K.3
Ito, T.4
Udaka, N.5
Ohji, H.6
Okudera, K.7
Okada, S.8
Kitamura, H.9
-
8
-
-
0034724957
-
The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless mice
-
Yamanaka K., Katsumata K., Ikuma K., Hasegawa A., Nakano M., Okada S. The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless mice. Cancer Lett. 152:2000;79-85.
-
(2000)
Cancer Lett.
, vol.152
, pp. 79-85
-
-
Yamanaka, K.1
Katsumata, K.2
Ikuma, K.3
Hasegawa, A.4
Nakano, M.5
Okada, S.6
-
9
-
-
0034986099
-
Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter
-
Yamanaka K., Mizoi M., Kato K., Hasegawa A., Nakano M., Okada S. Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter. Biol. Pharm. Bull. 24:2001;510-514.
-
(2001)
Biol. Pharm. Bull.
, vol.24
, pp. 510-514
-
-
Yamanaka, K.1
Mizoi, M.2
Kato, K.3
Hasegawa, A.4
Nakano, M.5
Okada, S.6
-
10
-
-
0031461075
-
Metabolic methylation is a possible genotoxicity-enhancing process of inorganic arsenics
-
Yamanaka K., Hayashi H., Tachikawa M., Kato K., Hasegawa A., Oku N., Okada S. Metabolic methylation is a possible genotoxicity-enhancing process of inorganic arsenics. Mutat. Res. 394:1997;95-101.
-
(1997)
Mutat. Res.
, vol.394
, pp. 95-101
-
-
Yamanaka, K.1
Hayashi, H.2
Tachikawa, M.3
Kato, K.4
Hasegawa, A.5
Oku, N.6
Okada, S.7
-
11
-
-
0035055929
-
Methylated trivalent arsenic species are genotoxic
-
Mass M.J., Tennant A., Roop B.C., Cullen W.R., Styblo M., Thomas D.J., Kligerman A.D. Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 14:2001;355-361.
-
(2001)
Chem. Res. Toxicol.
, vol.14
, pp. 355-361
-
-
Mass, M.J.1
Tennant, A.2
Roop, B.C.3
Cullen, W.R.4
Styblo, M.5
Thomas, D.J.6
Kligerman, A.D.7
-
12
-
-
0033841975
-
Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells
-
Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74:2000;289-299.
-
(2000)
Arch. Toxicol.
, vol.74
, pp. 289-299
-
-
Styblo, M.1
Del Razo, L.M.2
Vega, L.3
Germolec, D.R.4
LeCluyse, E.L.5
Hamilton, G.A.6
Reed, W.7
Wang, C.8
Cullen, W.R.9
Thomas, D.J.10
-
13
-
-
0035341194
-
Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes
-
Vega L., Styblo M., Patterson R., Cullen W., Wang C., Germolec D. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 172:2001;225-232.
-
(2001)
Toxicol. Appl. Pharmacol.
, vol.172
, pp. 225-232
-
-
Vega, L.1
Styblo, M.2
Patterson, R.3
Cullen, W.4
Wang, C.5
Germolec, D.6
-
14
-
-
0027248786
-
A chemical hypothesis for arsenic methylation in mammals
-
Thompson D.J. A chemical hypothesis for arsenic methylation in mammals. Chem. Biol. Interact. 88:1993;89-114.
-
(1993)
Chem. Biol. Interact.
, vol.88
, pp. 89-114
-
-
Thompson, D.J.1
-
16
-
-
0028218716
-
Reduction and binding of arsenate and dimethylarsinate by glutathione: A magnetic resonance study
-
Delnomdedieu M., Basti M.M., Otvos J.D., Thomas D.J. Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance study. Chem. Biol. Interact. 90:1994;139-155.
-
(1994)
Chem. Biol. Interact.
, vol.90
, pp. 139-155
-
-
Delnomdedieu, M.1
Basti, M.M.2
Otvos, J.D.3
Thomas, D.J.4
-
17
-
-
0020997378
-
Micronuclei in circulating erythrocytes: a rapid screen for chromosomal damage during routine toxicity testing in mice
-
in: A.W. Hayes, R.C. Schnell, T.S. Miya (Eds.), Elsevier, Amsterdam
-
J.T. Macgregor, R. Schlegel, W.N. Choy, C.M. Wehr, Micronuclei in circulating erythrocytes: a rapid screen for chromosomal damage during routine toxicity testing in mice, in: A.W. Hayes, R.C. Schnell, T.S. Miya (Eds.), Developments in the Science and Practice of Toxicology, Elsevier, Amsterdam, 1983, pp. 555-558.
-
(1983)
Developments in the Science and Practice of Toxicology
, pp. 555-558
-
-
Macgregor, J.T.1
Schlegel, R.2
Choy, W.N.3
Wehr, C.M.4
-
18
-
-
0035863773
-
In vivo genotoxicity evaluation of dimethylarsinic acid in MutaMouse
-
Noda Y., Suzuki T., Kohara A., Hasegawa A., Yotsuyanagi T., Hayashi M., Sofuni T., Yamanaka K., Okada S. In vivo genotoxicity evaluation of dimethylarsinic acid in MutaMouse. Mutat. Res. 513:2002;205-212.
-
(2002)
Mutat. Res.
, vol.513
, pp. 205-212
-
-
Noda, Y.1
Suzuki, T.2
Kohara, A.3
Hasegawa, A.4
Yotsuyanagi, T.5
Hayashi, M.6
Sofuni, T.7
Yamanaka, K.8
Okada, S.9
-
19
-
-
0026330605
-
Arsenite as the probable active species in the human carcinogenicity of arsenic: Mouse micronucleus assays on Na and K arsenite, orpiment, and Fowler's solution
-
Tinwell H., Stephens S.C., Ashby J. Arsenite as the probable active species in the human carcinogenicity of arsenic: mouse micronucleus assays on Na and K arsenite, orpiment, and Fowler's solution. Environ. Health Perspect. 95:1991;205-210.
-
(1991)
Environ. Health Perspect.
, vol.95
, pp. 205-210
-
-
Tinwell, H.1
Stephens, S.C.2
Ashby, J.3
-
20
-
-
0022534429
-
In vivo studies in male mice on the mutagenic effects of inorganic arsenic
-
Deknudt G., Leonard A., Arany J., Buisson G.J., Delavignette E. In vivo studies in male mice on the mutagenic effects of inorganic arsenic. Mutagenesis. 1:1986;33-34.
-
(1986)
Mutagenesis
, vol.1
, pp. 33-34
-
-
Deknudt, G.1
Leonard, A.2
Arany, J.3
Buisson, G.J.4
Delavignette, E.5
-
21
-
-
0028177360
-
Active oxygen species are involved in the induction of micronuclei by arsenite in XRS-5 cells
-
Wang T.S., Huang H. Active oxygen species are involved in the induction of micronuclei by arsenite in XRS-5 cells. Mutagenesis. 9:1994;253-257.
-
(1994)
Mutagenesis
, vol.9
, pp. 253-257
-
-
Wang, T.S.1
Huang, H.2
-
22
-
-
0025203206
-
The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides
-
Hayashi M., Morita T., Kodama Y., Sofuni T., Ishidate M. Jr. The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat. Res. 245:1990;245-249.
-
(1990)
Mutat. Res.
, vol.245
, pp. 245-249
-
-
Hayashi, M.1
Morita, T.2
Kodama, Y.3
Sofuni, T.4
Ishidate M., Jr.5
-
24
-
-
0034667885
-
Arsenic species that cause release of iron from ferritin and generation of activated oxygen
-
Ahmad S., Kitchin K.T., Cullen W.R. Arsenic species that cause release of iron from ferritin and generation of activated oxygen. Arch. Biochem. Biophys. 382:2000;195-202.
-
(2000)
Arch. Biochem. Biophys.
, vol.382
, pp. 195-202
-
-
Ahmad, S.1
Kitchin, K.T.2
Cullen, W.R.3
-
25
-
-
0033429606
-
Dimethylarsinic acid exposure causes accumulation of Hsp72 in cell nuclei and suppresses apoptosis in human alveolar cultured (L-132) cells
-
Kato K., Yamanaka K., Hasegawa A., Okada S. Dimethylarsinic acid exposure causes accumulation of Hsp72 in cell nuclei and suppresses apoptosis in human alveolar cultured (L-132) cells. Biol. Pharm. Bull. 22:1999;1185-1188.
-
(1999)
Biol. Pharm. Bull.
, vol.22
, pp. 1185-1188
-
-
Kato, K.1
Yamanaka, K.2
Hasegawa, A.3
Okada, S.4
-
26
-
-
0029917374
-
Dimethylarsinic acid causes apoptosis in HL-60 cells via interaction with glutathione
-
Ochi T., Nakajima F., Sakurai T., Kaise T., Oya-Ohta Y. Dimethylarsinic acid causes apoptosis in HL-60 cells via interaction with glutathione. Arch. Toxicol. 70:1996;815-821.
-
(1996)
Arch. Toxicol.
, vol.70
, pp. 815-821
-
-
Ochi, T.1
Nakajima, F.2
Sakurai, T.3
Kaise, T.4
Oya-Ohta, Y.5
-
27
-
-
0028351241
-
Glutathione plays different roles in the induction of the cytotoxic effects of inorganic and organic arsenic compounds in cultured BALB/c 3T3 cells
-
Ochi T., Kaise T., Oya-Ohta Y. Glutathione plays different roles in the induction of the cytotoxic effects of inorganic and organic arsenic compounds in cultured BALB/c 3T3 cells. Experientia. 50:1994;115-120.
-
(1994)
Experientia
, vol.50
, pp. 115-120
-
-
Ochi, T.1
Kaise, T.2
Oya-Ohta, Y.3
-
28
-
-
0030601667
-
Induction of chromosomal aberrations in cultured human fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction
-
Oya-Ohta Y., Kaise T., Ochi T. Induction of chromosomal aberrations in cultured human fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction. Mutat. Res. 357:1996;123-129.
-
(1996)
Mutat. Res.
, vol.357
, pp. 123-129
-
-
Oya-Ohta, Y.1
Kaise, T.2
Ochi, T.3
-
30
-
-
0031845110
-
Arsenite inhibits mitotic division and perturbs spindle dynamics in HeLa S3 cells
-
Huang S.C., Lee T.C. Arsenite inhibits mitotic division and perturbs spindle dynamics in HeLa S3 cells. Carcinogenesis. 19:1998;889-896.
-
(1998)
Carcinogenesis
, vol.19
, pp. 889-896
-
-
Huang, S.C.1
Lee, T.C.2
-
31
-
-
0034721764
-
The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic
-
Kala S.V., Neely N.W., Kala G., Prater C.I., Atwood D.W., Rice J.S., Lieberman M.W. The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 275:2000;33404-33408.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 33404-33408
-
-
Kala, S.V.1
Neely, N.W.2
Kala, G.3
Prater, C.I.4
Atwood, D.W.5
Rice, J.S.6
Lieberman, M.W.7
|